BIOTECHNOLOGY NEWS

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed [...]

By digitalstudios|2026-09-18T14:26:20+00:00September 18, 2026|3rd Party Medical Device Industry News|Comments Off

Heraeus Medical has expanded its portfolio with the strategic business [...]

By digitalstudios|2026-09-10T14:34:28+00:00September 10, 2026|3rd Party Medical Device Industry News|Comments Off

Collaboration with AAV-specialist CDMO will support scalable production of EPY201 [...]

By digitalstudios|2026-09-09T13:16:15+00:00September 9, 2026|3rd Party Medical Device Industry News|Comments Off